Trials / Completed
CompletedNCT02386813
International Extranodal NK/T-cell Lymphoma Project
International Extranodal NK/T-cell Lymphoma Project: Prognostic Factors in the Era of Nonanthracycline-based Treatment
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 770 (actual)
- Sponsor
- Samsung Medical Center · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study is to explore risk factors for poor progression-free survival (PFS) and overall survival (OS) in ENKTL, and establish a prognostic model for ENKTL patients treated with non-anthracycline based treatment.
Detailed description
This is a retrospective cohort study using anonymized information from patients with ENKTL. The following criteria are required: (1) Patients diagnosed with ENKTL, nasal type between January 1, 1995 and December 31, 2014; (2) Patients treated with non-anthracycline based therapy as an initial treatment. The pathology of initial diagnosis was reviewed by designated pathologists.
Conditions
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2015-06-01
- Completion
- 2015-06-01
- First posted
- 2015-03-12
- Last updated
- 2017-04-11
Locations
2 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02386813. Inclusion in this directory is not an endorsement.